drugset / Trial / NCT01154790
Phase I Study on Multiple Oral Dosing of CG100649
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of 3 escalating loading and maintenance dose regimens of CG100649 administered orally for 7 total days in healthy volunteers.
Timeline
- Start
- 2010-06
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naproxen | Small molecule | — | — |
| Subject | Polmacoxib | Other / unclassified | — | Oral |
Indications
No indication recorded.